Thy1 + nk cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes

PLoS Pathogens

Volumn 7, Issue 8, 2011, Pages

  Gillard, Geoffrey O ^a   Bivas Benita, Maytal ^a   Hovav, Avi Hai ^a,b   Grandpre, Lauren E ^a   Panas, Michael W ^a   Seaman, Michael S ^a   Haynes, Barton F ^c   Letvin, Norman L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR; THY 1 ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; LIVER CELL; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE; VACCINIA VIRUS; VIRAL CLEARANCE; ANIMAL; IMMUNOLOGY; LIVER; VACCINIA;

MUS; POXVIRIDAE; VACCINIA VIRUS;

ANIMALS; ANTIGENS, THY-1; FEMALE; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; LIVER; MICE; VACCINIA; VACCINIA VIRUS;

EID: 80052334104     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002141     Document Type: Article

References (44)

1. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH, (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7: 507-516.
2. Sun JC, Beilke JN, Lanier LL, (2009) Adaptive immune features of natural killer cells. Nature 457: 557-561.
3. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, et al. (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 11: 1127-1135.
4. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826-8831.
5. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL, (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
6. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, et al. (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
7. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951-956.
8. Lee SH, Webb JR, Vidal SM, (2002) Innate immunity to cytomegalovirus: the Cmv1 locus and its role in natural killer cell function. Microbes Infect 4: 1491-1503.
9. Lee SH, Zafer A, de Repentigny Y, Kothary R, Tremblay ML, et al. (2003) Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med 197: 515-526.
10. Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, et al. (2003) Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A 100: 13483-13488.
11. Cheng TP, French AR, Plougastel BF, Pingel JT, Orihuela MM, et al. (2008) Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 60: 565-573.
12. Xu R, Johnson AJ, Liggitt D, Bevan MJ, (2004) Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172: 6265-6271.
13. Kitamura D, Roes J, Kuhn R, Rajewsky K, (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
14. Hasan M, Polic B, Bralic M, Jonjic S, Rajewsky K, (2002) Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation on the BALB/c background. Eur J Immunol 32: 3463-3471.
15. Ghobrial RR, Boublik M, Winn HJ, Auchincloss H Jr, (1989) In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol 52: 486-506.
16. Carbone A, Harbeck R, Dallas A, Nemazee D, Finkel T, et al. (1991) Alpha beta T-lymphocyte depleted mice, a model for gamma delta T-lymphocyte functional studies. Immunol Rev 120: 35-50.
17. Seo N, Tokura Y, Takigawa M, Egawa K, (1999) Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 163: 242-249.
18. Phillips JH, Lanier LL, (1986) Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 164: 814-825.
19. Kalland T, Belfrage H, Bhiladvala P, Hedlund G, (1987) Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells. J Immunol 138: 3640-3645.
20. Salup RR, Mathieson BJ, Wiltrout RH, (1987) Precursor phenotype of lymphokine-activated killer cells in the mouse. J Immunol 138: 3635-3639.
21. Karupiah G, Coupar BE, Andrew ME, Boyle DB, Phillips SM, et al. (1990) Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol 144: 290-298.
22. Ikeda S, Tominaga T, Nishimura C, (1991) Thy 1+ asialo GM1+ dendritic epidermal cells in skin defense mechanisms of vaccinia virus-infected mice. Arch Virol 117: 207-218.
23. Peterson JM, Barbul A, Breslin RJ, Wasserkrug HL, Efron G, (1987) Significance of T-lymphocytes in wound healing. Surgery 102: 300-305.
24. Kim S, Iizuka K, Kang HS, Dokun A, French AR, et al. (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3: 523-528.
25. Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, et al. (2007) NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol 178: 4764-4770.
26. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, et al. (2009) Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 106: 1915-1919.
27. Ramirez JC, Gherardi MM, Esteban M, (2000) Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J Virol 74: 923-933.
28. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
29. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
30. Arnon TI, Markel G, Mandelboim O, (2006) Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16: 348-358.
31. Mendelson M, Tekoah Y, Zilka A, Gershoni-Yahalom O, Gazit R, et al. (2010) NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol 84: 3789-97.
32. Delano ML, Brownstein DG, (1995) Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J Virol 69: 5875-5877.
33. Brownstein DG, Gras L, (1997) Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen. Am J Pathol 150: 1407-1420.
34. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH, (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1: 119-126.
35. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, et al. (2002) The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19-29.
36. Lanier LL, (2005) NKG2D in innate and adaptive immunity. Adv Exp Med Biol 560: 51-56.
37. Raulet DH, (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
38. Diefenbach A, Hsia JK, Hsiung MY, Raulet DH, (2003) A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 33: 381-391.
39. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH, (2001) Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413: 165-171.
40. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, et al. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727.
41. Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C, (2008) NKG2D ligands: key targets of the immune response. Trends Immunol 29: 397-403.
42. Fang M, Lanier LL, Sigal LJ, (2008) A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog 4: e30.
43. Earl PL, Cooper N, Wyatt LS, Moss B, Carroll MW, (2001) Preparation of cell cultures and vaccinia virus stocks. Curr Protoc Mol Biol Chapter 16: Unit16 16.
44. Rodriguez JF, Rodriguez D, Rodriguez JR, McGowan EB, Esteban M, (1988) Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A 85: 1667-1671.